ArticleGenome medicine2023

Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.

Yeon Hee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.